OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Macrocyclic Inhibitors of HGF-Activating Serine Proteases Overcome Resistance to Receptor Tyrosine Kinase Inhibitors and Block Lung Cancer Progression
Vishnu C. Damalanka, Jorine Voss, Matthew Mahoney, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 24, pp. 18158-18174
Open Access | Times Cited: 11
Vishnu C. Damalanka, Jorine Voss, Matthew Mahoney, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 24, pp. 18158-18174
Open Access | Times Cited: 11
Showing 11 citing articles:
Macrocycles and macrocyclization in anticancer drug discovery: Important pieces of the puzzle
Chao Zhang, Fenfen Liu, You‐Ming Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116234-116234
Closed Access | Times Cited: 20
Chao Zhang, Fenfen Liu, You‐Ming Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116234-116234
Closed Access | Times Cited: 20
Inhibition of autocrine HGF maturation overcomes cetuximab resistance in colorectal cancer
Vivian Truong Jones, Ramona Graves‐Deal, Zheng Cao, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 6
Vivian Truong Jones, Ramona Graves‐Deal, Zheng Cao, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 6
HGF/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis
Alpha Raj Mekapogu, Zhihong Xu, Srinivasa Pothula, et al.
Cancer Letters (2023) Vol. 568, pp. 216286-216286
Open Access | Times Cited: 11
Alpha Raj Mekapogu, Zhihong Xu, Srinivasa Pothula, et al.
Cancer Letters (2023) Vol. 568, pp. 216286-216286
Open Access | Times Cited: 11
A perspective on the application of macrocyclic design strategies in antitumor drugs
Yanhong Li, Yukang Lin, Junjie Cai, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108190-108190
Closed Access
Yanhong Li, Yukang Lin, Junjie Cai, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108190-108190
Closed Access
Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA , matriptase, and hepsin
Matthew Mahoney, Jonathan Helander, Anoopjit Singh Kooner, et al.
Protein Science (2024) Vol. 33, Iss. 8
Open Access | Times Cited: 3
Matthew Mahoney, Jonathan Helander, Anoopjit Singh Kooner, et al.
Protein Science (2024) Vol. 33, Iss. 8
Open Access | Times Cited: 3
Mechanism-Based Macrocyclic Inhibitors of Serine Proteases
Vishnu C. Damalanka, Victoria S. Banas, Paolo De Bona, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4833-4854
Closed Access | Times Cited: 2
Vishnu C. Damalanka, Victoria S. Banas, Paolo De Bona, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4833-4854
Closed Access | Times Cited: 2
Cyclic Peptides as Protein Kinase Modulators and Their Involvement in the Treatment of Diverse Human Diseases
Lorena Martínez-Alcántar, Laura Hernández-Padilla, Alma Laura Díaz-Pérez, et al.
Kinases and Phosphatases (2024) Vol. 2, Iss. 4, pp. 346-378
Open Access | Times Cited: 1
Lorena Martínez-Alcántar, Laura Hernández-Padilla, Alma Laura Díaz-Pérez, et al.
Kinases and Phosphatases (2024) Vol. 2, Iss. 4, pp. 346-378
Open Access | Times Cited: 1
Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells
M.C. Rodenas, Julia Peñas-Martínez, Irene Pardo-Sánchez, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 3
M.C. Rodenas, Julia Peñas-Martínez, Irene Pardo-Sánchez, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 3
Hepsin promotes breast tumor growth signaling via the TGFβ‐EGFR axis
Denis Belitškin, Pauliina Munne, Shishir M. Pant, et al.
Molecular Oncology (2023) Vol. 18, Iss. 3, pp. 547-561
Open Access | Times Cited: 3
Denis Belitškin, Pauliina Munne, Shishir M. Pant, et al.
Molecular Oncology (2023) Vol. 18, Iss. 3, pp. 547-561
Open Access | Times Cited: 3
Current Developments of Synthetic Cyclopeptides as Potential Anticancer Agents (A Review)
Meng Tang, Xiaojuan Zhang, Zheng Chen, et al.
Russian Journal of General Chemistry (2023) Vol. 93, Iss. 11, pp. 2973-2994
Closed Access | Times Cited: 1
Meng Tang, Xiaojuan Zhang, Zheng Chen, et al.
Russian Journal of General Chemistry (2023) Vol. 93, Iss. 11, pp. 2973-2994
Closed Access | Times Cited: 1
Cancer – Proteases in Progression and Metastasis
Kyungmin Ji, Bonnie F. Sloane
Elsevier eBooks (2022), pp. 712-726
Closed Access
Kyungmin Ji, Bonnie F. Sloane
Elsevier eBooks (2022), pp. 712-726
Closed Access
